Smith, Moore & Co’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$774K Sell
11,226
-622
-5% -$42.9K 0.07% 242
2025
Q1
$803K Sell
11,848
-498
-4% -$33.7K 0.07% 234
2024
Q4
$554K Sell
12,346
-4,219
-25% -$189K 0.05% 274
2024
Q3
$1.04M Sell
16,565
-3,583
-18% -$225K 0.1% 176
2024
Q2
$1.19M Buy
20,148
+53
+0.3% +$3.13K 0.12% 153
2024
Q1
$1.6M Sell
20,095
-9,414
-32% -$751K 0.17% 121
2023
Q4
$2.33M Sell
29,509
-5,222
-15% -$412K 0.27% 76
2023
Q3
$2.42M Sell
34,731
-1,576
-4% -$110K 0.32% 68
2023
Q2
$2.51M Buy
36,307
+3,256
+10% +$225K 0.32% 66
2023
Q1
$2.46M Buy
33,051
+1,256
+4% +$93.3K 0.33% 64
2022
Q4
$2.96M Buy
31,795
+13
+0% +$1.21K 0.41% 45
2022
Q3
$3.03M Sell
31,782
-1,109
-3% -$106K 0.46% 44
2022
Q2
$3.05M Sell
32,891
-661
-2% -$61.3K 0.47% 42
2022
Q1
$3.4M Buy
33,552
+1,203
+4% +$122K 0.46% 43
2021
Q4
$3.34M Buy
32,349
+188
+0.6% +$19.4K 0.46% 42
2021
Q3
$2.73M Buy
32,161
+306
+1% +$26K 0.42% 50
2021
Q2
$2.66M Buy
31,855
+490
+2% +$40.9K 0.4% 51
2021
Q1
$2.36M Sell
31,365
-1,199
-4% -$90.2K 0.38% 54
2020
Q4
$2.22M Buy
32,564
+10,622
+48% +$725K 0.42% 51
2020
Q3
$1.28M Buy
21,942
+1,973
+10% +$115K 0.27% 72
2020
Q2
$1.3M Buy
19,969
+214
+1% +$13.9K 0.29% 69
2020
Q1
$1.17M Buy
19,755
+670
+4% +$39.7K 0.31% 66
2019
Q4
$1.42M Sell
19,085
-1,551
-8% -$115K 0.29% 67
2019
Q3
$1.3M Buy
20,636
+7,168
+53% +$452K 0.29% 66
2019
Q2
$734K Buy
13,468
+3,494
+35% +$190K 0.17% 125
2019
Q1
$538K Buy
9,974
+194
+2% +$10.5K 0.13% 160
2018
Q4
$641K Buy
9,780
+647
+7% +$42.4K 0.17% 126
2018
Q3
$719K Sell
9,133
-1,436
-14% -$113K 0.16% 126
2018
Q2
$680K Buy
10,569
+2,615
+33% +$168K 0.17% 127
2018
Q1
$495K Buy
7,954
+871
+12% +$54.2K 0.13% 154
2017
Q4
$514K Buy
7,083
+1,157
+20% +$84K 0.14% 146
2017
Q3
$482K Buy
+5,926
New +$482K 0.14% 147